In this video, Jeff Yu, MD, MS, emphasized the importance of chronic hand eczema awareness and highlighted a study on the causes and treatments of the disease, presented at the Revolutionizing Atopic ...

In this video, Jeff Yu, MD, MS, highlighted research from the Revolutionizing Atopic Dermatitis, or RAD, meeting and said the disease has “leapt to the forefront” of dermatologic diseases with ...

The artist has lately been derided as a colonizer and a pedophile, the creep of the Post-Impressionists. A new book ...

When Rachel Evans developed a rash that made her feel as though she had 'insects crawling all over her body', doctors ...

The trial aims to assess the safety and efficacy of tralokinumab 300mg administered biweekly as a single agent.

Atopic dermatitis is the most common type of eczema and affects ~16.5 million adults and 9.6 million children in the US. The ...

Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

A new dermatology office is now open in Chesterfield County, providing another option for area residents looking for treatment for conditions like acne, eczema and more.

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main ...

Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B ...